Komori
Earnings4406New Japan Chemical Co.,Ltd.Materials and Chemicals

Summary of Financial Results for the Fiscal Year Ending March 2026 [Japanese GAAP] (Consolidated)

For the fiscal year ended March 2026, net sales decreased slightly, while operating income and ordinary income declined substantially. Net income attributable to owners of the parent increased. For the fiscal year ending March 2027, the Company forecasts operating income and ordinary income of ¥800 million each and annual dividends of ¥4.50 per share.

Worth reading
49Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Mixed performance
Direction inferred from the company’s description.
Scale
30.5
% (year-on-year decrease in operating income)
Wording
Conditional
How definitive the wording is.

Results for this period

Full year1 April 2025–31 March 2026ConsolidatedJapanese GAAP
Net Sales32,105¥ millionYear on year -1.8%Progress 98.8%
Operating profit576¥ millionYear on year -30.5%Progress 72.0%
Ordinary income547¥ millionYear on year -54.2%Progress 68.4%
Net income attributable to owners of the parent597¥ millionYear on year +14.5%

The width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.

Net income per share¥16.03
Operating Margin1.8%
Financial position at period-end
Total assets40,345¥ million
of which net assets 20,987 ¥ millionEquity ratio 48.9%vs. prior year-end +1.5pt

塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.

Cash inflows and outflows
Operating+1,643
Investment+501
Financials-64
Net change+2,080

Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ million).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.

Cash and cash equivalents at end of period¥5,532 million
Outlook and shareholder returns
Full-year earnings forecast
Net Sales¥32,500 million (YoY +1.2%)
Operating profit¥800 million (YoY +38.9%)
Ordinary income¥800 million (YoY +46.1%)
Profit attributable to owners of the parent¥600 million (YoY +0.4%)
Annual Dividend Forecast¥4.00 → ¥4.50(+12.5%)
Payout ratio28.1%
Factors Behind Changes in Business Performance

Profitability was pressured by lower sales of products for the automotive industry due to the Trump tariffs, intensified inflows of low-priced products from overseas manufacturers, weak end demand resulting from the slowdown in the Chinese economy, and higher naphtha prices.

Disclosure regarding the going concern assumption

Not applicable.

Change in accounting policy
基準改正に伴う変更 Noそれ以外の変更 No見積りの変更 No修正再表示 No
Changes in the scope of consolidationNew Number of companies 2 / Company name NJC Europe Ltd., NJC America Inc. / Excluded Number of companies 1 / Company name Nice Rika Biotechnologies Sdn. Bhd.
Material subsequent eventsNot applicable.
Breakdown of extraordinary income (loss)Extraordinary income Gain on sale of non-current assets ¥0 million, Gain on sale of investment securities ¥824 million / Extraordinary loss Loss on waiver of receivables from an affiliated company ¥150 million, Loss on sale of investment securities ¥38 million, Loss on closure of a plant ¥504 million
Depreciation and amortization¥755 million
Availability of Supplementary Financial Results MaterialsNo
Availability of Financial Results BriefingNo
Issued Shares at Period-End37,286,906 Shares
Treasury Shares at Period-End4,632 Shares
Results for this period
ItemDetails
Fiscal Period ClassificationFull year
Accounting standardsJapanese GAAP
Consolidated / non-consolidatedConsolidated
Period Covered1 April 2025–31 March 2026
Net Sales¥32,105 million (YoY -1.8%)
Operating profit¥576 million (YoY -30.5%)
Ordinary income¥547 million (YoY -54.2%)
Profit attributable to owners of the parent¥597 million (YoY +14.5%)
Net income per share¥16.03
Operating Margin1.8%
Equity ratioEnd of the current fiscal period 48.9% / End of previous period 47.4%
Total assets¥40,345 million
Net assets¥20,987 million
Cash flows from operating activities¥1,643 million
Cash flows from investing activities¥501 million
Cash flows from financing activities¥-64 million
Cash and cash equivalents at end of period¥5,532 million
Full-year earnings forecastNet Sales ¥32,500 million (YoY +1.2%) / Operating profit ¥800 million (YoY +38.9%) / Ordinary income ¥800 million (YoY +46.1%) / Profit attributable to owners of the parent ¥600 million (YoY +0.4%)
Annual Dividend Forecast¥4.00 → ¥4.50(+12.5%)
Payout ratio28.1%
Depreciation and amortization¥755 million
Breakdown of extraordinary income (loss)Extraordinary income Gain on sale of non-current assets ¥0 million, Gain on sale of investment securities ¥824 million / Extraordinary loss Loss on waiver of receivables from an affiliated company ¥150 million, Loss on sale of investment securities ¥38 million, Loss on closure of a plant ¥504 million
Disclosure regarding the going concern assumptionNot applicable.
Change in accounting policyChanges due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No
Changes in the scope of consolidationNew Number of companies 2 / Company name NJC Europe Ltd., NJC America Inc. / Excluded Number of companies 1 / Company name Nice Rika Biotechnologies Sdn. Bhd.
Material subsequent eventsNot applicable.
Availability of Supplementary Financial Results MaterialsNo
Availability of Financial Results BriefingNo
Issued Shares at Period-End37,286,906 Shares
Treasury Shares at Period-End4,632 Shares
Factors Behind Changes in Business PerformanceProfitability was pressured by lower sales of products for the automotive industry due to the Trump tariffs, intensified inflows of low-priced products from overseas manufacturers, weak end demand resulting from the slowdown in the Chinese economy, and higher naphtha prices.
Items this document does not state (7)
Revision to Earnings ForecastShareholder Return PolicySegment revenueSegment profitRegional salesOrders received and order backlogImpairment loss

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Profitability was pressured by lower sales of products for the automotive industry due to the Trump tariffs, intensified inflows of low-priced products from overseas manufacturers, weak end demand resulting from the slowdown in the Chinese economy, and higher naphtha prices.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Summary of Financial Results for the Fiscal Year Ending March 2026 [Japanese GAAP] (Consolidated) | New Japan Chemical Co.,Ltd. (4406) timely disclosure | Komori